Biomarkers in Urothelial Cancer Patients Treated With Pembrolizumab

Clinical trial NCT03263039 · UNKNOWN

Trial details

NCT number: NCT03263039
Sponsor: Erasmus Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Transitional Cell Carcinoma of the Bladder Biomarkers

Start date: 2017-08-21
Primary completion: 2022-08-19
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.